痴呆不止是记忆丧失:痴呆神经精神症状的非药物与药物管理
该综述基于已发表的荟萃分析,评估痴呆神经精神症状(NPS)非药物与药物干预的有效性和安全性。NPS见于超过90%的痴呆患者,与更高发病率、死亡率、照护者负担和护理院安置风险相关。证据表明多种非药物干预有益并推荐为一线治疗,药物治疗应保留给较重或难治性NPS或非药物管理不可行时。
要点
- NPS见于超过90%的痴呆患者,与更高发病率、死亡率及照护者负担相关。
- 多种非药物干预对NPS管理有益,推荐为一线治疗。
- 药物治疗应保留给较重或难治性NPS或非药物管理不可行时。
核心结论
- 证据表明多种非药物干预对NPS管理有益并推荐为一线治疗,药物治疗应保留给较重或难治性NPS或非药物管理不可行时。
研究设计与样本
- 综述,主要基于已发表的荟萃分析评估NPS非药物和药物干预的有效性与安全性。
主要发现
- NPS见于超过90%的痴呆患者,与更高发病率、死亡率、照护者负担和倦怠、护理院安置高风险及照护费用增加相关。
- 非药物干预中多种对NPS管理有益,推荐为一线治疗。
- 非典型抗精神病药在减少NPS方面多显示 modest 获益,其使用受不良反应特征限制。
- 常用处方药包括非典型抗精神病药、乙酰胆碱酯酶抑制剂、美金刚、抗抑郁药和心境稳定剂。
- 大麻素类、重复经颅磁刺激和ECT在NPS患者中的数据有限。
关键数值与推荐
- NPS见于超过90%的痴呆患者。
- 非药物干预推荐为一线治疗。
- 药物治疗保留给较重或难治性NPS或非药物管理不可行时。
临床怎么用
- 使用标准化评估工具如神经精神量表(NPI)可帮助定性和定量NPS。
- 非药物干预应作为NPS管理的一线治疗。
- 药物治疗应保留给较重或难治性NPS或非药物管理不可行时。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neuropsychiatric symptoms of dementia (NPS) are a group of noncognitive symptoms that occur in over 90% of individuals with dementia. NPS seem to result from a complex interaction among various biological, psychosocial, and environmental factors, and they are associated with greater morbidity and mortality, higher caregiver burden and burnout, high risk of nursing home placement, and increased cost of care for patients with dementia. Use of standardized assessment tools like the Neuropsychiatric Inventory can assist with qualifying and quantifying NPS. In this review, the authors evaluate the evidence for efficacy and safety of nonpharmacological and pharmacological interventions for treating NPS, mostly based on published meta-analyses. Commonly prescribed medications include atypical antipsychotics, acetylcholinesterase inhibitors, memantine, antidepressants, and mood stabilizers. There are also limited data on cannabinoids, repetitive transcranial magnetic stimulation, and ECT in individuals with NPS. Available evidence indicates that several nonpharmacological interventions are beneficial in the management of NPS and are recommended as first-line treatments. Pharmacotherapy should be reserved for the treatment of more severe or refractory NPS or where nonpharmacological management is not feasible. Atypical antipsychotics have shown mostly modest benefit in reducing NPS, and their use is limited by their adverse effect profiles. Recent investigations suggest potential strategies for preventing or at least reducing the risk of dementia and NPS. The authors conclude with brief guidelines for clinical practice as well as future research.
引用
- Tampi RR, Jeste DV. Dementia Is More Than Memory Loss: Neuropsychiatric Symptoms of Dementia and Their Nonpharmacological and Pharmacological Management. Am J Psychiatry. 2022. PMID: 35921394. doi:10.1176/appi.ajp.20220508
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。